Cargando…

Study protocol for using a smartphone application to investigate speech biomarkers of Parkinson’s disease and other synucleinopathies: SMARTSPEECH

INTRODUCTION: Early identification of Parkinson’s disease (PD) in its prodromal stage has fundamental implications for the future development of neuroprotective therapies. However, no sufficiently accurate biomarkers of prodromal PD are currently available to facilitate early identification. The voc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kouba, Tomáš, Illner, Vojtěch, Rusz, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247696/ https://www.ncbi.nlm.nih.gov/pubmed/35772829 http://dx.doi.org/10.1136/bmjopen-2021-059871

Ejemplares similares

Correlations of Neuropsychological and Metabolic Brain Changes in Parkinson's Disease and Other α-Synucleinopathies
por: Trošt, Maja, et al.
Publicado: (2019)

Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies
por: Menon, Sindhu, et al.
Publicado: (2022)

Autonomic Dysfunction in α-Synucleinopathies
por: Mendoza-Velásquez, José Javier, et al.
Publicado: (2019)

Accuracy of Rating Scales and Clinical Measures for Screening of Rapid Eye Movement Sleep Behavior Disorder and for Predicting Conversion to Parkinson’s Disease and Other Synucleinopathies
por: Skorvanek, Matej, et al.
Publicado: (2018)

Glucocerebrosidase Involvement in Parkinson Disease and Other Synucleinopathies
por: Almeida, Maria do Rosário
Publicado: (2012)

Multilingual evaluation of interpretable biomarkers to represent language and speech patterns in Parkinson's disease
por: Favaro, Anna, et al.
Publicado: (2023)

Endoplasmic Reticulum-Based Calcium Dysfunctions in Synucleinopathies
por: Kovacs, Gergo, et al.
Publicado: (2021)

Skin Biopsy as a Diagnostic Tool for Synucleinopathies
por: Waqar, Sara, et al.
Publicado: (2023)

Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson’s disease and other synucleinopathies
por: Magalhães, Pedro, et al.
Publicado: (2022)

Sex differences in alpha-synucleinopathies: a systematic review
por: Raheel, Kausar, et al.
Publicado: (2023)

Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other Synucleinopathies
por: Terkelsen, Miriam Højholt, et al.
Publicado: (2022)

Molecular chaperones and protein folding as therapeutic targets in Parkinson’s disease and other synucleinopathies
por: Ebrahimi-Fakhari, Darius, et al.
Publicado: (2013)

Deep Brain Stimulation Does Not Modulate Auditory-Motor Integration of Speech in Parkinson's Disease
por: Bahners, Bahne H., et al.
Publicado: (2020)

Automated analysis of connected speech reveals early biomarkers of Parkinson’s disease in patients with rapid eye movement sleep behaviour disorder
por: Hlavnička, Jan, et al.
Publicado: (2017)

Distinct Incidence of Takotsubo Syndrome Between Amyotrophic Lateral Sclerosis and Synucleinopathies: A Cohort Study
por: Izumi, Yuishin, et al.
Publicado: (2018)

Smartphone Applications in the Management of Parkinson's Disease in a Family Setting: An Opinion Article
por: Zhang, Ting, et al.
Publicado: (2021)

The Efficacy of Tai Chi and Stretching Exercises Based on a Smartphone Application for Patients With Parkinson's Disease: A Protocol for a Randomized Controlled Trial
por: Ma, Renyan, et al.
Publicado: (2021)

More than meets the eye in Parkinson’s disease and other synucleinopathies: from proteinopathy to lipidopathy
por: Flores-Leon, Manuel, et al.
Publicado: (2023)

Pathological looping in the synucleinopathies: investigating the link between Parkinson’s disease and Gaucher disease
por: Kinghorn, Kerri J.
Publicado: (2011)

Short-term effect of dopaminergic medication on speech in early-stage Parkinson’s disease
por: Tykalova, Tereza, et al.
Publicado: (2022)

Prevalence and incidence of Parkinson’s disease and other forms of parkinsonism in a cohort of elderly individuals in Southern Brazil: protocol for a population-based study
por: Pereira, Gabriela Magalhães, et al.
Publicado: (2021)

Differences in spontaneous speech fluency between Parkinson's disease and spinocerebellar ataxia type 3
por: dos Santos, Vanessa Brzoskowski, et al.
Publicado: (2023)

A study on the correlations between acoustic speech variables and bradykinesia in advanced Parkinson's disease
por: Cavallieri, Francesco, et al.
Publicado: (2023)

Speech and gait abnormalities in motor subtypes of de‐novo Parkinson's disease
por: Rusz, Jan, et al.
Publicado: (2023)

Slurring of Speech and Lip Paresthesia: Symptoms of Levodopa End of Dose Wearing Off in Parkinson's Disease
por: Nasir, Usama, et al.
Publicado: (2018)

Editorial: Biomarkers of non-motor symptoms in Parkinson's disease and parkinsonisms
por: Filippi, Massimo, et al.
Publicado: (2023)

Distinct patterns of speech disorder in early-onset and late-onset de-novo Parkinson’s disease
por: Rusz, Jan, et al.
Publicado: (2021)

Dopaminergic Treatment Effects on Dysarthric Speech: Acoustic Analysis in a Cohort of Patients With Advanced Parkinson's Disease
por: Cavallieri, Francesco, et al.
Publicado: (2021)

Home-based exercise training by using a smartphone app in patients with Parkinson’s disease: a feasibility study
por: Putzolu, Martina, et al.
Publicado: (2023)

Linking the Endoplasmic Reticulum to Parkinson’s Disease and Alpha-Synucleinopathy
por: Colla, Emanuela
Publicado: (2019)

Evidence of Inflammation in Parkinson’s Disease and Its Contribution to Synucleinopathy
por: Lai, Thuy Thi, et al.
Publicado: (2022)

Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction
por: Calabresi, Paolo, et al.
Publicado: (2023)

Speech acoustic indices for differential diagnosis between Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy
por: Daoudi, Khalid, et al.
Publicado: (2022)

Speech Biomarkers in Rapid Eye Movement Sleep Behavior Disorder and Parkinson Disease
por: Rusz, Jan, et al.
Publicado: (2021)

Variable High-Frequency Deep Brain Stimulation of the Subthalamic Nucleus for Speech Disorders in Parkinson's Disease: A Case Report
por: Zhang, Chencheng, et al.
Publicado: (2019)

Biomarkers for Dementia, Fatigue, and Depression in Parkinson's Disease
por: Prell, Tino, et al.
Publicado: (2019)

Evaluation of phase-locking to parameterized speech envelopes
por: David, Wouter, et al.
Publicado: (2022)

Efficacy of idebenone in the Treatment of iRBD into Synucleinopathies (EITRS): rationale, design, and methodology of a randomized, double-blind, multi-center clinical study
por: Li, Yuanyuan, et al.
Publicado: (2022)

Speech Kinematics and Coordination Measured With an MEG-Compatible Speech Tracking System
por: Anastasopoulou, Ioanna, et al.
Publicado: (2022)

Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease
por: Milanese, Chiara, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jgtobii7li7iqg37f339fh9dp4